Aarti Pharmalabs Limited — Board Meeting, 12-08-2025: Outcome of Board Meeting

Aarti Pharmalabs' board met and approved the consolidated financial results for the quarter ended June 30, 2025. Revenue from operations stood at ₹386.19 Cr, with a net profit of ₹49.50 Cr, resulting in an EPS of ₹5.46. The board also cleared the re-appointment of Ms. Rupal Vora as an Independent Director for three years and the appointment of M/s Mehta and Mehta as Secretarial Auditors for five years, both pending shareholder approval. Additionally, the company approved extending its employee stock option scheme to subsidiary employees. Ganesh Polychem Limited became a joint venture effective April 1, 2025.